Fractyl’s Revita DMR System commercially available in Germany
Fractyl Health has announced the commercial availability of its Revita DMR System in Germany, an endoscopic procedural therapy that is...
Fractyl’s Revita DMR System commercially available in Germany
Fractyl Health reports latest Revita DMR outcomes for T2DM
Two-year Revita DMR outcomes show durability of procedure in diabetics
Fractyl gains US$100 million financing to expand clinical development programs for T2DM
Revita DMR granted FDA Breakthrough Device Designation for T2DM
INSPIRE: Revita DMR plus GLP-1RA shows durable insulin-free glycaemic control